Zastosowanie izotopowych testów oddechowych w diagnostyce przewodu pokarmowego

• Authors: Wieczorek Szymon , Kempiński Radosław , Poniewierka Elżbieta
• Languages of publication: PL

Keywords

PL

testy oddechowe; przewód pokarmowy; metody diagnostyczne

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2013
• Issue: 1
• Pages: 38-42

Contributors

author

Wieczorek Szymon

author

Kempiński Radosław

author

Poniewierka Elżbieta

References

• Malfertheiner P, Megraud F, O’Morain C, et al. The European Helicobacter Study Group (EHSG). Management of Helicobacter pylori infection – the Maastricht IV/Florence Consensus Report. Gut 2012; 61: 646–664.
• Dzieniszewski J, et al. Polish Helicobacter pylori consensus 2008. Gastroenterol Pol 2008; 15: 323–331.
• Piccinino F, Sagnelli E, Pasquale G, et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986; 2: 165–173.
• Hepner GW, Vessel ES. Assessment of aminopyrine metabolism in man after oral administration of 14C-aminopiryne. Effects of phenobarbital, disulfiram and portal cirrhosis. N Engl J Med 1974; 291: 1384–1388.
• Matsumoto K, Suehiro M, Iio M, et al. 13C-methacetin breath test for evaluation of liver demage. Dig Dis Sci 1987; 32: 344–348.
• Breen KJ, Bury RW, Calder IV A, et al. 14C-phenacetin breath test to measure hepatic function in man. Hepatology 1984; 4:47–52.
• Arnaud MJ, Thelin-Doerner A, Ravussin E, et al. Study of detmethylation of 1,2,7-methyl-13C-caffeine in man using respiratory exchange measurements. Biomed Mass Spectrom 1980; 7: 521–524.
• Hepner GW, Vessel ES, Lipton A, et al. Disposition of aminopyrine, antipyrine, diazepam and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlation in drug elimination. J Lab Clin Med 1977; 90: 440–456.
• Watkins PB , Murray SA, Winkelman LG, et al. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. J Clin Invest 1989; 83: 688–697
• Shreeve WW, Shoop JD, Ott DG, et al. Test for alcoholic cirrhosis conversion of 14C or 13C galactose to expired CO 2. Gastroenterology 1976; 72: 98–101.
• Burke PA , Stack JA, Wagner D, et al. L-1-13C-phenylalanine oxidation as a measure of hepatocyte functional capacity in endstage liver disease. Am J Surg 1997; 173: 270–274.
• Lautenburg BH, Liang D, Schwarzenbach FA, et al. Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis. Hepatology 1993; 17: 418–422.
• Armuzzi A, Maroccia S, Zocco MA , et al. Non-invasive assessment of human hepatic mitochondrial function through the v13C-methionine breath test. Scand J Gastroenterol 2000; 35: 650–653.
• Baker AL , Kotake AN , Scoeller DA . Clinical utility of breath tests for the assessment of hepatic function. Semin Liver Dis 1983;3: 318–329.
• 15. Braden B, Faust D, Sarrazin U, et al. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 2005; 21(Jan 15): 179–185.
• Saunders JB, Wright N, Lewis KO . Predicting outcome of paracetamol poisoning by using 14C-aminopyrine breath test. Br Med J 1980; 1: 279–280.
• Petrolati A, Festi D, De Berardinis G, et al. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther 2003; 15(18): 785–790.
• Lalazar G, Shuvy M, Pappo O, et al. Use of a 13C methacetin breath test (MBT ) for follow-up of patients with acute liver disease.J Hepatol 2006; 44: S63.
• Portincasa P, Grattagliano I, Lauterburg BH, et al. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis.Clin Sci (Lond) 2006; 111: 135–143.
• Chowdhury RS, Forsmark CE . Review article: pancreatic function testing. Aliment Pharmacol Ther 2003; 17: 733–750.
• Vantrappen GR, Rutgeerts PJ, Ghoos YF, et al. Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterology 1989; 96: 1126–1134.
• Murphy JL, Laiho KM , Jones AE , et al. Metabolic handling of 13C labelled tripalmitin in healthy controls and patients with cystic fibrosis. Arch Dis Child 1998; 79: 44–47.
• Kato H, Nakao A, Kishimoto W, et al. 13C-labeled trioctanoin breath test for exocrine pancreatic function test in patients after pancreatoduodenectomy. Am J Gastroenterol 1993; 88: 64–69.
• Ritz MA , Fraser RJ, Di Matteo AC , et al. Evaluation of the 13C-triolein breath test for fat malabsorption in adult patients with cystic fibrosis. J Gastroenterol Hepatol 2004; 19: 448–453.
• . Ventrucci M, Cipolla A, Ubalducci GM, et al. 13C labelled cholesteryl octanoate breath test for assessing pancreatic exocrine insufficiency. Gut 1998; 42: 81–87.
• Evenepoel P, Hiele M, Geypens B, et al. 13C-egg white breath test: a non-invasive test of pancreatic trypsin activity in the small intestine. Gut 2000; 46: 52–57.
• Symonds EL , Kritas S, Omari TI , et al. A combined 13CO 2/H2 breath test can be used to assess starch digestion and fermentation in humans. J Nutr 2004; 134: 1193–1196.
• Löser C, Brauer C, Aygen S, et al. Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test. Scand J Gastroenterol 1998; 33: 327–334.
• Rana SV, Bhardwaj SB. Small intestinal bacterial overgrowth. Scand J Gastroenterol 2008; 43: 1030–1037.
• Solomons NW, Schoeller DA , Wagonfeld JB, et al. Application of a stable isotope (13C)-labeled glycocholate breath test to diagnosis of bacterial overgrowth and ileal dysfunction. J Lab Clin Med 1977; 90: 431–439.
• Dellert SF, Nowicki MJ, Farrell MK , et al. The 13C-xylose breath test for the diagnosis of small bowel bacterial overgrowth in children. J Pediatr Gastroenterol Nutr 1997; 25: 153–158
• Lewis SJ, Young G, Mann M, et al. Improvement in specificity of [14C]d-xylose breath test for bacterial overgrowth. Dig Dis Sci 1997; 42: 1587–1592.
• Fromm H, Hofmann AF. Breath test for altered bile-acid metabolism. Lancet 1971; 298: 621–625.
• Choi MG, Camilleri M, Burton DD , et al. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 1998; 93: 92–98.
• Maes BD , Ghoos YF, Geypens BJ, et al. Combined carbon-13-glycine/carbon-14-octanoic acid breath test to monitor gastric emptying rates of liquids and solids. J Nucl Med 1994; 35: 824–831.
• Braden B, Adams S, Duan LP , et al. The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology 1995; 108: 1048–1055.
• Chew CG, Bartholomeusz FD, Bellon M, et al. Simultaneous 13C/14C dual isotope breath test measurement of gastric emptying of solid and liquid in normal subjects and patients: comparison with scintigraphy. Nucl Med Rev Cent East Eur 2003; 6: 29–33.
• Van den Driessche M, Van Malderen N, Geypens B, et al. Lactose-[13C]ureide breath test: a new, noninvasive technique to determine orocecal transit time in children. J Pediatr Gastroenterol Nutr 2000; 31: 433–438.
• Hiele M, Ghoos Y, Rutgeerts P, et al. 13CO 2 breath test using naturally 13C-enriched lactose for detection of lactase deficiency in patients with gastrointestinal symptoms. J Lab Clin Med 1988; 112: 193–200.
• Ritchie BK , Brewster DR , Geoffrey P, et al. 13C-sucrose breath test: novel use of a noninvasive biomarker of environmental gut health. Pediatrics 2009; 124: 620–626.
• Hoekstra JH, van den Aker JHL, Kneepkens CM F, et al. Evaluation of 13CO 2 breath tests for the detection of fructose malabsorption.J Lab Clin Med 1996; 127: 304–310
• Tveito K, Brunborg C, Sandvik L, et al. 13C-xylose and 14C-xylose breath tests for the diagnosis of coeliac disease. Scand J Gastroenterol 2008; 43: 166–173.
• Tveito K, Hetta AK , Askedal M, et al. A novel one-hour 13C-sorbitol breath test versus the H2-sorbitol breath test for assessment of coeliac disease. Scand J Gastroenterol 2009; 44: 813–819.
• Mattison LK , Ezzeldin H, Carpenter M, et al. Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath test. Clin Cancer Res 2004; 15: 2652–2658.